Pheochromocytoma	pheochromocytoma	O	O	OTHERS	I
unmasked	unmasked	O	O	O	O
by	by	O	O	O	O
amisulpride	amisulpride	O	O	OTHERS	I
and	and	O	O	O	O
tiapride	tiapride	O	O	OTHERS	I
.	.	O	O	O	O

OBJECTIVE	objective	O	O	O	O
:	:	O	O	O	O
To	to	O	O	O	O
describe	describe	O	O	O	O
the	the	O	O	O	O
unmasking	unmasking	O	O	O	O
of	of	O	O	O	O
pheochromocytoma	pheochromocytoma	O	O	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
patient	patient	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
amisulpride	amisulpride	O	O	OTHERS	I
and	and	O	O	O	O
tiapride	tiapride	O	O	OTHERS	I
.	.	O	O	O	O

CASE	case	O	O	O	O
SUMMARY	summary	O	O	O	O
:	:	O	O	O	O
A	a	O	O	O	O
42-year-old	42-year-old	O	O	O	O
white	white	O	O	O	O
man	man	O	O	O	O
developed	developed	O	O	O	O
acute	acute	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
with	with	O	O	O	O
severe	severe	O	O	O	O
headache	headache	O	DISEASE	OTHERS	I
and	and	O	O	O	O
vomiting	vomiting	O	DISEASE	OTHERS	I
2	2	O	O	O	O
hours	hours	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
amisulpride	amisulpride	O	O	OTHERS	I
100	100	O	O	O	O
mg	mg	O	O	OTHERS	I
and	and	O	O	O	O
tiapride	tiapride	O	O	OTHERS	I
100	100	O	O	O	O
mg	mg	O	O	OTHERS	I
.	.	O	O	O	O

Both	both	O	O	O	O
drugs	drugs	O	O	O	O
were	were	O	O	O	O
immediately	immediately	O	O	O	O
discontinued	discontinued	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
recovered	recovered	O	O	O	O
after	after	O	O	O	O
subsequent	subsequent	O	O	O	O
nicardipine	nicardipine	O	O	OTHERS	I
and	and	O	O	O	O
verapamil	verapamil	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
.	.	O	O	O	O

Abdominal	abdominal	O	O	O	O
ultrasound	ultrasound	O	O	O	O
showed	showed	O	O	O	O
an	an	O	O	O	O
adrenal	adrenal	O	O	O	O
mass	mass	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
postoperative	postoperative	O	O	O	O
histologic	histologic	O	O	O	O
examination	examination	O	O	O	O
confirmed	confirmed	O	O	O	O
the	the	O	O	O	O
diagnosis	diagnosis	O	O	O	O
of	of	O	O	O	O
pheochromocytoma	pheochromocytoma	O	O	OTHERS	I
.	.	O	O	O	O

DISCUSSION	discussion	O	O	O	O
:	:	O	O	O	O
Drug-induced	drug-induced	O	O	O	O
symptoms	symptoms	O	O	O	O
of	of	O	O	O	O
pheochromocytoma	pheochromocytoma	O	O	OTHERS	I
are	are	O	O	O	O
often	often	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
substituted	substituted	O	O	O	O
benzamide	benzamide	O	O	OTHERS	I
drugs	drugs	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
the	the	O	O	O	O
underlying	underlying	O	O	O	O
mechanism	mechanism	O	O	O	O
is	is	O	O	O	O
unknown	unknown	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
our	our	O	O	O	O
case	case	O	O	O	O
,	,	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
Naranjo	naranjo	O	O	O	O
probability	probability	O	O	O	O
scale	scale	O	O	O	O
indicated	indicated	O	O	O	O
a	a	O	O	O	O
possible	possible	O	O	O	O
relationship	relationship	O	O	O	O
between	between	O	O	O	O
the	the	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
crisis	crisis	O	O	O	O
and	and	O	O	O	O
amisulpride	amisulpride	O	O	OTHERS	I
and	and	O	O	O	O
tiapride	tiapride	O	O	OTHERS	I
therapy	therapy	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
As	as	O	O	O	O
of	of	O	O	O	O
March	march	O	O	O	O
24	24	O	O	O	O
,	,	O	O	O	O
2005	2005	O	O	O	O
,	,	O	O	O	O
this	this	O	O	O	O
is	is	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
reported	reported	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
amisulpride-	amisulpride-	O	O	O	O
and	and	O	O	O	O
tiapride-induced	tiapride-induced	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
crisis	crisis	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
patient	patient	O	O	O	O
with	with	O	O	O	O
pheochromocytoma	pheochromocytoma	O	O	OTHERS	I
.	.	O	O	O	O

Physicians	physicians	O	O	O	O
and	and	O	O	O	O
other	other	O	O	O	O
healthcare	healthcare	O	O	O	O
professionals	professionals	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
aware	aware	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
potential	potential	O	O	O	O
adverse	adverse	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
tiapride	tiapride	O	O	OTHERS	I
and	and	O	O	O	O
amisulpride	amisulpride	O	O	OTHERS	I
.	.	O	O	O	O

